UTI Asset Management Company Ltd

- UTI AMC and its subsidiaries are investing in expanding their geographical presence including opening new offices in New York, USA, and Paris, France, as well as enhancing the Middle East operations by upgrading regulatory licenses in DIFC. - Significant investments are being made in hiring and upskilling human capital across geographies such as the USA, France, Singapore, Dubai, and within India to support future business growth. - There is a focus on digital resource augmentation, including partnerships like with Salesforce, revisiting digital assets, and strengthening risk management processes globally. - UTI Pension Fund Limited is building a strong sales and distribution network with 16 branch offices across Bharat to increase private sector market share. - The company is launching new products across business lines and investing in brand building, product distribution, and operation upgrades for medium-to-long-term growth. - Initial establishment and rental costs of international offices (Paris and USA) have contributed to increased expenses but are strategic investments for future growth.

- Focus on absolute profit growth rather than yield, as yield margins may decline due to asset mix and inflows, but overall profit will increase with volume growth (Imtaiyazur Rahman). - PAT margin expected to improve due to operating leverage and volume growth, despite declining yield margins (Vinay Lakhotia). - Significant improvement in SIP inflows driven by fintech, banks, distributors, and better fund performance; strong inflows expected to sustain (Sandeep Samsi). - Alternative business anticipated to become core PAT positive from next financial year, adding to overall profitability (Vinay Lakhotia). - Expansion internationally (offices in Paris, USA, Singapore, Dubai) and investments in subsidiaries expected to drive growth (Vinay Lakhotia, Imtaiyazur Rahman). - Market share gains targeted through improved fund performance, distribution, and product positioning (Imtaiyazur Rahman). - Overall growth supported by strong industry trends and rising investor participation, especially in SIP and ETFs.

- Focus on absolute profit growth rather than yield, with overall profit expected to rise despite yield pressure (Imtaiyazur Rahman, Page 16). - PAT margin expected to improve due to operating leverage and volume growth, although yield margins may decline due to asset mix and fresh inflows (Vinay Lakhotia, Page 16). - UTI Alternative expected to turn core PAT positive from the beginning of next financial year, adding to standalone profits (Vinay Lakhotia, Page 14). - Overall consolidated PAT for H1 FY25 increased 18% YoY to ₹493 crore; standalone PAT up 29% YoY for H1 FY25 (Page 6). - Employee cost increase guided at 2%-3% standalone and ~4% consolidated, with cost efficiencies expected from lean sales model and retirements (Page 12). - Digital and geographic expansions to support future growth, balanced by controlled cost increases (Pages 11-12). - Better fund performances and improved market share expected to drive sustainable growth in assets under management and profits.

The provided pages from the UTI Asset Management Company Limited Q2 & H1 FY25 Earnings Conference Call transcript do not mention any details related to a current or expected orderbook or pending orders. The discussion primarily focuses on: - Fund performance, SIP inflows, and AUM growth. - Revenue yields and profitability metrics. - Employee costs and branch expansions. - Market share, product strategy, and business segment outlook. - Subsidiaries' performance and future expectations. - Commission rationalization and cost management. No information on orderbook or pending orders is available in the provided text.

- UTI Alternatives subsidiary is in the process of closing SDOF-I and SDOF-II funds, expected to be fully closed soon. - Existing funds currently in fund-raising mode within UTI Alternatives will be entering their financial close shortly. - No explicit mention of new or future fundraising through equity; focus is on debt-related fund closures and new product launches in alternatives. - Emphasis on launching appropriate new products across all business lines, including alternatives, indicating potential future fundraising initiatives. - No direct reference to equity capital raising in the discussion.